Connect with us

Health

Puberty blockers could cause long-term fertility and health issues for boys, study finds: ‘May be permanent’

Published

on

Puberty blockers could cause long-term fertility and health issues for boys, study finds: ‘May be permanent’

Puberty blockers have been shown to cause long-term fertility problems in boys, according to a preprint study from Mayo Clinic.

The study, which has not yet been peer-reviewed, analyzed more than 130,000 sperm cells from male children with gender dysphoria. 

All participants were 17 or younger.

TRANS CHILDREN WHO TOOK PUBERTY-BLOCKING DRUGS HAD MENTAL HEALTH ISSUES, UK STUDY FOUND

The researchers analyzed the testicular cells of boys who had been taking puberty blockers for anywhere from three months to 52 months, and compared them to cells of a control group who had not been on the blockers.

Advertisement

Among those on puberty blockers, the researchers identified mild to severe “sex gland atrophy,” determining that the medications accelerated the aging and function of testicular cells.

Puberty blockers have been shown to cause long-term fertility problems in boys, according to a Mayo Clinic preprint study. (iStock)

The findings suggest that puberty blockers’ impacts may be permanent — disputing claims that such effects can be reversed.

The researchers also detected cases of microlithiasis, which is marked by the presence of small clusters of calcium in the testicles.

‘GENDER-AFFIRMING’ TREATMENTS DON’T BENEFIT YOUTH, SAYS PEDIATRICIANS GROUP: ‘IRREVERSIBLE CONSEQUENCES’

Advertisement

Additional research from Mayo Clinic has linked testicular microlithiasis to an increased risk of testicular cancer

“We provide unprecedented histological evidence revealing detrimental pediatric testicular sex gland responses to [puberty blockers],” the authors wrote in the study findings.

Doctors highlight the risks

Dr. Marc Siegel, clinical professor of medicine at NYU Langone Medical Center and a Fox News medical contributor, was not involved in the Mayo Clinic research but commented on the use of puberty blockers.

“Thousands of U.S. children — more than ever before — are experiencing gender dysphoria and many go on to identify as transgender,” Siegel told Fox News Digital. 

Dr. Marc Siegel, left, of New York, and Dr. Brett Osborn, right, of Florida, both offered thoughts on the potential risks of puberty-blocking medications. (Dr. Marc Siegel/Dr. Brett Osborn)

Advertisement

“They certainly still face a stigma for this, which needs to be addressed — but at the same time, the growing rush to gender-affirming treatment is disturbing, particularly without parental approval.”

In 2021, approximately 42,167 children received gender dysphoria diagnoses, almost triple the 15,172 reported in 2017, according to Reuters.

“Much of this is politically driven, and may lead to premature treatments that are not offered in the U.K., Finland, Sweden or many other countries,” Siegel said.

EXPOSING THE TRANS AGENDA AIMED AT OUR KIDS: FAITH LEADER REVEALS HOW PARENTS CAN KEEP CHILDREN SAFE

Among the puberty-blocking drugs is lupron (leuprolide), which is a type of hormone therapy used for advanced prostate cancer. 

Advertisement

It is also used to stop early puberty in children, according to WebMD.

“It helps to delay sexual development (such as growth of the breasts/testicles) and the start of menstrual periods,” WebMD reported. 

“It also helps slow down early bone growth to increase the likelihood of reaching normal adult height.”

In the majority of cases, one physician recommends that any hormonal interventions should be delayed until an older age. (iStock)

The U.S. Food and Drug Administration (FDA) reported 10,000 adverse effects in children in 2017 — including mood swings, cognitive problems, suicidal thoughts, longer-term fertility problems, seizures, migraines, brittle bones, brain swelling and vision loss, according to Siegel.

Advertisement

Experts also warn of the potential mental impacts of these drugs.

“Transgender individuals are three times more likely than the general population to suffer from anxiety, depression and neurodevelopmental issues,” Siegel warned. 

“Much of this is politically driven, and may lead to premature treatments.”

Although some studies have shown that interventions such as puberty blockers may decrease anxiety in the short term, Siegel pointed out that “there are no longer-term head-to-head trials versus extensive therapy and watchful waiting.” 

Puberty blockers typically lead children down a path to long-term use of transgender-affirming hormones, such as estrogen and testosterone, he noted.

Advertisement

Puberty blockers typically lead children down a path to long-term use of transgender-affirming hormones, such as estrogen and testosterone, according to doctors. (iStock)

“These hormones carry their own risks — for example, estrogen may increase the incidence of breast cancer,” Siegel said.

“Bottom line, I don’t believe puberty blockers should be given routinely to children and teens for gender dysphoria,” Siegel said. “There are too many long-term risks, including the idea that the children or teens may change their minds.”

SURFER BETHANY HAMILTON SPEAKS OUT AGAINST NEW RULE ALLOWING TRANSGENDER WOMEN TO COMPETE WITH FEMALES

In the majority of cases, Siegel recommends that any hormonal interventions or gender reassignment surgeries be delayed until an older age.

Advertisement

He added, “Intensive supportive and cognitive therapy makes sense as an initial approach.”

“Transgender individuals are three times more likely than the general population to suffer from anxiety, depression and neurodevelopmental issues,” Dr. Marc Siegel of New York warned.  (iStock                       )

Dr. Brett Osborn, a Florida neurologist and longevity expert who was also not involved in the new research, noted that previous studies have shown that puberty-blocking drugs can alter the normal progression of testicular cells, potentially leading to atrophy or abnormal development.

“Specifically, the drugs impact the normal function of ‘spermatogonial’ stem cells (SSCs), which are crucial for sperm production and overall reproductive health,” he told Fox News Digital.

“The changes induced by these medications may be permanent, contrary to popular opinion among transgender activists.”

Advertisement

“Disruption in their development could result in reduced fertility or other reproductive issues later in life,” he continued. “Based on the researchers’ histologic findings, the changes induced by these medications may be permanent, contrary to popular opinion among transgender activists.”

Added Osborn, “These medications are not as benign as billed.”

Hormones such as testosterone, progesterone and estrogen are critical for brain development, memory and cognition, one doctor noted. (iStock)

The risks go beyond infertility, the doctor warned.

“There are also downrange effects of altered hormone levels on brain development, let alone other organ systems,” he said. 

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Hormones such as testosterone, progesterone and estrogen are critical for brain development, memory and cognition, Osborn pointed out. 

The doctor called for “safer and more effective” treatments for those with gender dysphoria.

“Gaining insight into the full impact of these medications – the usage of which has become more prevalent — is crucial for future generations.”

Advertisement

Fox News Digital reached out to the Mayo Clinic researchers for comment.

For more Health articles, visit www.foxnews.com/health.

Advertisement

Health

Scientists pinpoint why COVID vaccine may trigger heart inflammation in certain people

Published

on

Scientists pinpoint why COVID vaccine may trigger heart inflammation in certain people

NEWYou can now listen to Fox News articles!

POST-DOSE PATTERN — New research reveals why the COVID vaccine can trigger heart issues, especially in one group

PREVENTION PAYOFF — Simple lifestyle changes could slash heart attack risk for millions

A new study has identified why mRNA COVID-19 vaccines could trigger heart issues, especially in one demographic. (iStock)

SMOKE SCREEN — A major cannabis study finds little proof for popular medical claims and flags big dangers

Advertisement

HIDDEN LINK — A common dental health issue may hint at a dangerous cardiovascular condition

SIGN UP FOR OUR HEALTH NEWSLETTER

SCREENING DEBATE A new study questions whether annual mammograms are necessary for most women

SUPER SPREAD — An “aggressive” new flu variant sweeps the globe as doctors warn of severe symptoms

The flu season has intensified as the new H3N2 variant causes severe illness worldwide. (iStock)

Advertisement

DANGEROUS DEFICIT — A nutrient deficiency has been linked to heart disease risk for millions

LIKE WHAT YOU’RE READING? CLICK HERE FOR MORE HEALTH NEWS

CORONARY CHRISTMAS — Holiday heart attacks spike as doctors share hidden triggers and prevention tips

Continue Reading

Health

Aging-related joint disorder increasingly affects people under 40, study finds

Published

on

Aging-related joint disorder increasingly affects people under 40, study finds

NEWYou can now listen to Fox News articles!

Cases of gout are rising in younger individuals, according to a global study.

The condition, which is a type of inflammatory arthritis, steadily increased in people aged 15 to 39 between 1990 and 2021, researchers in China announced.

Although rates vary widely between countries, the total number of young people with the condition is expected to continue rising through 2035.

WEIGHT LOSS DRUGS COULD ADD YEARS TO AMERICANS’ LIVES, RESEARCHERS PROJECT

Advertisement

The study, published in the journal Joint Bone Spine, investigated 2021 data from the Global Burden of Disease (GBD), spanning 204 countries within the 30-year timeframe.

The data measured gout prevalence, incidence and years lived with disability, tracking global trends over time. The results showed a global increase across all three outcomes.

Gout is expected to continue rising in young people through 2035. (iStock)

Prevalence and disability years increased by 66%, and incidence rose by 62%. In 2021, 15- to 39-year-olds accounted for nearly 14% of new gout cases globally, the study found.

Men from 35 to 39 years old and people in high-income regions had the highest burden, but high-income North America topped the list for highest rates.

Advertisement

‘SKINNY FAT’ WARNING ISSUED AS STUDY FINDS HIDDEN OBESITY BEHIND NORMAL BMI

Men were also found to have lived more years with gout due to high BMI, while women tended to have the condition as a link to kidney dysfunction, the study noted.

The total number of cases is expected to increase globally due to population growth, but the study projected that rates per population would decrease.

The researchers noted that data quality, especially in low-income settings, could have posed a limitation to the broad GBD data.

What is gout?

Gout is a common form of arthritis involving sudden and severe attacks of pain, swelling, redness and tenderness in the joints, according to Mayo Clinic. It most often occurs in the big toe.

Advertisement

CLICK HERE FOR MORE HEALTH STORIES

The condition occurs when urate crystals accumulate in the joint. These form when there are high levels of uric acid in the blood, which the body produces when it breaks down a natural substance called purines.

A gout flare-up can happen at any time, often at night, causing the affected joint to feel hot, swollen, tender and sensitive to the touch.

Urate crystals, described as sharp and needle-like, build up in the joint, causing intense pain and swelling. (iStock)

Purines can also be found in certain foods, like red meat or organ meats like liver and some seafood, including anchovies, sardines, mussels, scallops, trout and tuna, according to the Mayo Clinic. Alcoholic drinks, especially beer, and drinks sweetened with fruit sugar can also lead to higher uric acid levels.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Uric acid will typically dissolve in the blood and pass through the kidneys into urine, but when the body produces too much or too little uric acid, it can cause a build-up of urate crystals. These are described by the Mayo Clinic as sharp and needle-like, causing pain, inflammation and swelling in the joint or surrounding tissue.

Risk factors for gout include a diet rich in high-purine foods and being overweight, which causes the body to produce more uric acid and the kidneys to have trouble eliminating it.

Experts urge patients to seek medical attention for gout flare-ups. (iStock)

Certain conditions like untreated high blood pressure, diabetes, obesity, metabolic syndrome and heart and kidney diseases can increase the risk of gout, as well as certain medications.

Advertisement

A family history of gout can also increase risk. Men are more likely to develop the condition, as women tend to have lower uric acid levels, although symptoms generally develop after menopause.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Untreated gout can cause worsening pain and joint damage, experts caution. It may also lead to more severe conditions, such as recurrent gout, advanced gout and kidney stones.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The Mayo Clinic advises patients to seek immediate medical care if a fever occurs or if a joint becomes hot and inflamed, which is a sign of infection. Certain anti-inflammatory medications can help treat gout flares and complications.

Advertisement

Fox News Digital reached out to the researchers for comment.

Continue Reading

Health

New study questions whether annual mammograms are necessary for most women

Published

on

New study questions whether annual mammograms are necessary for most women

NEWYou can now listen to Fox News articles!

A new study suggests that annual mammograms may not be the only effective approach for preventing breast cancer.

The research, published in the Journal of the American Medical Association (JAMA), tested a risk-based breast cancer screening approach against standard annual mammography.

The WISDOM randomized clinical trial, led by study authors from universities and healthcare systems across the U.S., considered more than 28,000 women aged 40 to 74 years old, splitting them into a risk-based screening group and an annual mammography group.

ERIN ANDREWS HAD ‘NO SYMPTOMS’ BEFORE CANCER DIAGNOSIS, PUSHES FOR EARLY SCREENINGS

Advertisement

Researchers calculated each woman’s individual risk based on genetics (sequencing of nine breast cancer genes) and other health factors. 

A new study suggests that annual mammograms may not be the only effective approach for preventing breast cancer. (iStock)

Those who were at the highest risk were advised to alternate between a mammogram and an MRI scan every six months. Patients with elevated risk were told to get an annual mammography and counseling.

Average-risk women were guided to get mammograms every two years, while low-risk individuals were advised to have no screening until they became higher risk or reached age 50.

HIDDEN TYPE OF BREAST CANCER COULD BE EXPOSED BY NEW BREAKTHROUGH TECH

Advertisement

The researchers found that risk-based screening did not lead to more advanced cancer diagnoses (stage 2B or higher) compared with annual screening, indicating that it is just as safe as traditional methods. The risk-based approach, however, did not reduce the number of biopsies overall, as researchers had hoped.

Among the risk-based group of women, those with higher risk had more screening, biopsies and detected cancers. Women at lower risk had fewer procedures.

The research, published in the Journal of the American Medical Association (JAMA), tested a risk-based breast cancer screening approach against standard annual mammography. (iStock)

“[The] findings suggest that risk-based breast cancer screening is a safe alternative to annual screening for women aged 40 to 74 years,” the researchers noted in the research summary. “Screening intensity matched individual risk, potentially reducing unnecessary imaging.”

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

Fox News medical contributor Dr. Nicole Saphier, associate professor of radiology at Memorial Sloan Kettering Cancer Center in New Jersey, commented that while these findings are important, the study “completely sidelines” what screenings are designed to do — detect cancer early.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“If you don’t measure stage 0, stage 1 or stage 2A cancers, you can’t tell whether personalized screening delays diagnosis in a way that matters for survival and treatment intensity,” Saphier, who was not involved in the study, told Fox News Digital in an interview.

Those who were at the highest risk were advised to alternate between a mammogram and an MRI scan every six months. (iStock)

More than 60% of breast cancers in the U.S. are diagnosed at stage 1 or 2A, where cure rates exceed 90%, the doctor noted.

Advertisement

The trial doesn’t “fully evaluate” whether risk-based screening changes detection at the earliest and most treatable stages, where screening “delivers its greatest benefit,” according to Saphier.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“Mammography is not without risk — radiation exposure, false positives, anxiety and potential over-diagnosis are real and should be acknowledged,” she said. “But it remains the most effective, evidence-based tool for detecting breast cancer early, when treatment is most successful.”

The expert added that labeling women under 50 as “low risk” is “outdated,” as breast cancer diagnoses are on the rise in younger females.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

“Until long-term mortality data support alternative approaches, annual screening beginning at 40 for average risk women should continue,” Saphier added. “Women should be assessed for breast cancer risk by 25 years old to determine if screening should begin earlier.”

Continue Reading

Trending